Epion Therapeutics</a> (Copy)
2 known investors
Find your way into Epion Therapeutics</a> (Copy)
Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Epion Therapeutics</a> (Copy) do?
- Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.
- Who are Epion Therapeutics</a> (Copy)'s investors?
- Epion Therapeutics</a> (Copy)'s investors include 7G BioVentures, New World Angels.




